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A B S T R A C T
Long an important and useful tool in forensic genetic investigations, mitochondrial DNA (mtDNA) typing
continues to mature. Research in the last few years has demonstrated both that data from the entire
molecule will have practical beneﬁts in forensic DNA casework, and that massively parallel sequencing
(MPS) methods will make full mitochondrial genome (mtGenome) sequencing of forensic specimens
feasible and cost-effective. A spate of recent studies has employed these new technologies to assess
intraindividual mtDNA variation. However, in several instances, contamination and other sources of
mixed mtDNA data have been erroneously identiﬁed as heteroplasmy. Well vetted mtGenome datasets
based on both Sanger and MPS sequences have found authentic point heteroplasmy in approximately 25%
of individuals when minor component detection thresholds are in the range of 10–20%, along with
positional distribution patterns in the coding region that differ from patterns of point heteroplasmy in
the well-studied control region. A few recent studies that examined very low-level heteroplasmy are
concordant with these observations when the data are examined at a common level of resolution. In this
review we provide an overview of considerations related to the use of MPS technologies to detect mtDNA
heteroplasmy. In addition, we examine published reports on point heteroplasmy to characterize features
of the data that will assist in the evaluation of future mtGenome data developed by any typing method.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The speciﬁc genetic markers and procedures employed for DNA
testing of specimens in forensics currently depend primarily
upon the quality and quantity of DNA present, and additionally
on the known samples available for comparison. Though not a
unique identiﬁer, mitochondrial DNA (mtDNA) has long offered
advantages for certain forensic genetic analyses. MtDNA is
abundant relative to nuclear DNA in most human cells, with
each cell containing hundreds to thousands of copies of the
mitochondrial genome (mtGenome) [1]. For aged specimens in
which the DNA may be highly fragmented and damaged [2,3],
the high copy number of the mtGenome often means that mtDNA
data can be reliably generated even when attempts to type nuclear
DNA markers fail to produce a proﬁle. MtDNA is also generally* Corresponding author at: Institute of Legal Medicine, Medical University of
Innsbruck, Innsbruck, Austria. Tel.: +43 512 9003 70640; fax: +43 512 9003 73640.
E-mail address: walther.parson@i-med.ac.at (W. Parson).
http://dx.doi.org/10.1016/j.fsigen.2015.05.003
1872-4973/ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access a
nd/4.0/).present in abundance in samples that may contain little or no
intact nuclear DNA, such as hair shafts [4] and aged ﬁngernails [5].
As a result, mtDNA has been the historical marker of choice for
these sample types [6–10]. Additional beneﬁts of mtDNA in
forensic casework relate to the inheritance of the molecule, which
permits the use of maternal relatives as references for unknown
samples [6,11]. This is extremely valuable in a number of scenarios,
but particularly when the direct references or close relatives
required for kinship analyses based on autosomal markers are
unavailable.
Standard forensic comparisons employing mtDNA are typically
straightforward. Interpretation of the evidence generally entails a
direct comparison of the sequences obtained from the samples of
questioned origin to the sequences of known origin. When the
mtDNA sequences of both questioned (e.g. crime scene) and
known (e.g. suspect) samples are consistent across all positions
considered for interpretation, the samples cannot be excluded as
originating from the same source or same lineage [12]. On the ﬂip
side, non-matching mtDNA sequences between a questioned and
known sample (an exclusion) also provide useful information in article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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Genetics (ISFG) and the U.S. Scientiﬁc Working Group on DNA
Methods (SWGDAM) have published detailed guidelines on both
mtDNA sequence data development in the laboratory as well as
data analysis and interpretation [12–15].
Though routine mtDNA testing tends to be relatively straight-
forward, there are particular scenarios that introduce additional
complexity from the standpoint of interpretation. The most
common of these involves the observation of heteroplasmy.
Heteroplasmy refers to the presence of more than one mtDNA
haplotype within a single individual or tissue. Individuals may
possess mtDNA molecules that differ in their length (length
heteroplasmy; LHP), or at single nucleotide positions (point
heteroplasmy; PHP). Heteroplasmic variation of either type is
not used for exclusionary purposes in forensic match comparisons
of mtDNA proﬁles, owing to both (1) the high mutation rate of
mtDNA and the germ-line bottleneck in oogenesis, which can
result in complete homoplasmic shifts between generations
[16,17] and (2) the variation that has been observed between
different tissue types [18–24]. However, shared PHP between
maternal relatives can provide further support for non-exclusion
and, indeed, has proven to increase the strength of the mtDNA
evidence in a case of historical signiﬁcance [25].
The average mutation rate of mtDNA exceeds that of nuclear
DNA by at least an order of magnitude according to nucleotide
substitution rates reported in phylogenetic studies [26–29].
However, the mutation rate estimated from pedigree studies is
substantially higher, most likely due to the ﬁne-scale picture of
the mutation process provided at that level, before the changes
can be masked by the longer-term effects of homoplasy and
selection [30–32]. Both germline and somatic mtDNA mutations
occur with relative frequency, and are often observed in mtDNA
proﬁles as heteroplasmy.
Heteroplasmy is generally regarded as being the exception
rather than the rule. Nevertheless, it has been shown to occur with
appreciable frequency in the general population [19,33] and must
be considered in the interpretation of forensic evidence. To date,
studies based on Sanger technology have formed the basis of our
understanding and led to the development of appropriate
interpretation guidelines to accommodate it [14,15]. However,
the sensitivity and throughput of newer massively parallel
sequencing (MPS) technologies stand to further reﬁne our
knowledge of heteroplasmy.
As heteroplasmy generally presents in mtDNA sequence data
as a mixture (see Fig. S1 for an example from Sanger data),
distinguishing authentic mtDNA heteroplasmy (i.e. intra-
individual variation) from other causes of mixed data that
may result in the appearance of heteroplasmy adds a level of
complexity to data interpretation regardless of whether the data
are Sanger-based or MPS-based. Mixtures of mtDNA from
distinct individuals, contamination by nuclear mitochondrial
pseudogene (NUMT) sequences, and chemistry-based sequencing
errors all have contributed to problems in the detection and
reporting of homoplasmic mutations in past Sanger-based
mtDNA reference population datasets [34–36]. It stands to reason
that these issues have the potential to impact heteroplasmy
detection in haplotypes developed by MPS techniques as
well. Given the recent explosion of studies exploring the
inheritance, pattern and incidence of mtDNA heteroplasmy based
on MPS data [21,22,24,37–46], along with our expectation that
the detection and treatment of heteroplasmy will be one of the
key areas in which MPS inﬂuences current forensic mtDNA
testing practices, in this paper we discuss the detection and
authentication of mtDNA heteroplasmy in light of these
technological advances. In addition, we review mtGenome
heteroplasmy rates reported in Sanger and MPS-based studiesto provide a baseline understanding for both future MPS-based
studies and mtDNA casework application.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.05.003.
2. Detection of mtDNA heteroplasmy using MPS techniques
The past ten years have seen a dramatic advance in the
methods, chemistries and detection platforms available for DNA
data generation. These massively parallel technologies are rapidly
replacing more traditional methods of DNA sequencing and typing;
and although Sanger sequencing is still employed, it has largely
become a complementary rather than standalone technology in
many disciplines. MPS methods produce large volumes of
sequence data at extremely low cost relative to Sanger sequencing,
and over the past decade the technologies themselves, as well as
their applications, have evolved quickly. MPS has revolutionized
most ﬁelds of genetics and is now routinely applied to various
questions in medical genetics (e.g. personalized medicine and
genome-wide association studies), evolutionary biology, molecu-
lar anthropology, epidemiology, and metagenomics [47–49]. For
many of these applications, NGS is being used to produce sequence
data covering thousands of loci, or even entire organismal
genomes in a single sequencing run. For mtDNA sequencing in
the forensic context, the high throughput capacity of MPS can be
harnessed to develop mtDNA data at high depths of sequence
coverage for tens or hundreds of individuals. Indeed, several
studies have demonstrated the clear utility of MPS for mtDNA
sequencing [50–52], with the throughput and sensitivity of the
technology resulting in far more efﬁcient and cost-effective data
production than can be achieved via Sanger technology.
With regard to the identiﬁcation of heteroplasmy, the most
substantial difference between MPS and Sanger-type sequencing is
the overall sensitivity of the detection methods. With MPS, the
parallel sequencing of, and subsequent detection from, individual
source DNA templates can permit the discovery of very low
frequency molecules (<5%). Such authentic low-level sequence
variants are often imperceptible in Sanger-based capillary
electrophoresis (CE) trace data, which essentially reﬂect mtDNA
consensus sequences, and where the limit of detection is typically
described as being approximately 10–20%. For example, the
current GEDNAP (www.gednap.org) proﬁciency test program
expects participants to detect and report PHP in Sanger-based
data when the minor component exceeds 20% of the
major component based on visual estimation of peak heights
(C. Hohoff, personal communication), and a recent study detected
artiﬁcially-mixed mtDNA sequences at approximately 10% and
greater [24]. Experiments in the authors’ respective laboratories
have demonstrated that heteroplasmic variants representing
fewer than 10% of the mtDNA molecules or PCR products can be
detected from CE data (H. Niederstätter, unpublished; and M. Peck,
unpublished). However, detection of authentic heteroplasmy at
these lower levels has been position and/or mtGenome region-
speciﬁc rather than universal, and also highly dependent upon the
extent of sequence background/noise. These caveats apply to the
detection of really any heteroplasmy in electrophoretic data,
whether the minor variant represents more or less than 10% of the
mtDNA molecules – and, it is important to note, likely also apply to
MPS-based data. This may be particularly true in the case of poor
quality or very low DNA quantity forensic specimens, as well as in
regions of the mtGenome that are more challenging to sequence
(for instance, due to secondary structure or the local sequence
environment) and thus exhibit strand bias and/or reduced
coverage compared to the rest of the molecule [50–55].
Additionally, both the random and non-random sequencing errors
that are more apparent in MPS reads than consensus Sanger trace
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low-level heteroplasmy can be distinguished from noise [55,56].
MPS library preparation strategies based on capture of mtDNA
templates from a genomic DNA extract ([57,58], for example),
otherwise known as hybridization enrichment, can recover the
very short mtDNA fragments that are difﬁcult or impossible to
sequence using targeted PCR-based approaches. This technique
has been used in the ancient DNA community to sequence
exceptionally old specimens via MPS [57,59–61], and holds
promise for some forensic applications [62,63]. However, the
increased sensitivity of this sample preparation method for
highly degraded specimens comes with a cost: homologous
NUMTs are also more easily captured (as compared to a
long-range PCR approach [64]), and this may confound
heteroplasmy detection. MPS reads developed from highly
degraded DNA are also, of course, very short. As a result, it may
be more difﬁcult to determine the phasing of reads and thus the
overall haplotype of a low-level sequence – something that could
otherwise assist in the identiﬁcation of NUMT background.
Though NUMT ampliﬁcation does not pose a signiﬁcant challenge
with current mtDNA typing processes as applied to the CR
even when extremely short amplicons are employed, the results of
a few studies [64–66] suggest that NUMT detection should be
considered in a MPS framework. Fortunately, and as with current
Sanger sequence data, the identiﬁcation of NUMTs as the source of
very low-level mixed mtDNA data can almost certainly be
addressed with laboratory-based, bioinformatic, and other data
handling and review methods.
To date, the detection of mixed positions that may represent
heteroplasmy in Sanger-based data has primarily relied upon
repeated visual examination of properly aligned electropherogram
traces by experienced examiners. This approach to heteroplasmy
identiﬁcation is clearly unviable with MPS data, due to both
average sequence read depths that may range into the thousands
or tens of thousands, and the difﬁculty (or impossibility) of manual
manipulation of mapped sequence reads in most software
programs designed for MPS data handling. As a result, the
detection of mixed positions in MPS data will need to rely on
bioinformatic solutions.
A related but distinct issue is the determination or authentica-
tion of heteroplasmy as the cause of the mixed mtDNA data
observed at any given nucleotide position – and in this respect the
treatment of Sanger and MPS data may be quite similar. With
Sanger-based data, heteroplasmy may be conﬁrmed as the source
of mixed mtDNA data by the consistent application of a set of
criteria – which in past studies has included conditions such as
observation across PCR replicates, observation of the variant
nucleotide in both sequencing directions and in excess of any
noise/background in the sequence data, and the use of STR typing
to exclude contamination as the cause of multiple mixed positions.
In addition, but to a lesser extent due to the rarity of the issue in
Sanger-based data, PCR strategies designed to avoid NUMT
ampliﬁcation or comparison of any mixed positions to known
NUMTs, along with conﬁrmation via an alternative typing method
have also been employed [19,23,67,68]. Thus, heteroplasmies are
called in Sanger sequence data when other potential causes of
mtDNA mixtures have been excluded as reasonable possibilities. A
similar approach for authenticating heteroplasmy will be required
with MPS. It will be a matter of (1) recognizing the potential causes
of mtDNA mixtures aside from heteroplasmy and their potential
for impact on the data, and (2) developing and applying criteria
that address these causes and reduce the false positive hetero-
plasmy designation rate to the acceptable level. At its core this
approach is no different than what is presently applied to Sanger
data. However, it will likely require greater formalization given the
more quantitative nature, and sheer volume, of MPS data.Several of the MPS-based mtDNA publications to date
have developed laboratory processing and/or data evaluation
strategies to eliminate potential causes of mixed mtDNA data
and thereby authenticate heteroplasmy. For example, use of a
long-range PCR strategy or primers designed to avoid NUMT
ampliﬁcation; data ﬁltering by quality scores; “double-strand
conﬁrmation” (observation of the variant nucleotide in sequences
from both directions); a minimum number of variant nucleotide
observations; strand balance thresholds; frequency screening
in population data; comparison to NUMT compendiums or
alignment against the human reference genome hg19 to
ﬁlter NUMT sequences; and conﬁrmation by multiple typing
methods or distinct MPS technologies [21–24,37,38,40–42,45,
46,50,52,56,64,69,70]. Yet as the examinations detailed in
Section 3 illustrate, in some instances the measures applied
have been insufﬁcient in ﬂagging authentic heteroplasmy.
3. Incidence and pattern of human mtDNA heteroplasmy in
Sanger and MPS-based studies
Examinations of population-based mtDNA datasets developed
via Sanger sequencing have identiﬁed PHP in the CR in
approximately 6% of individuals when buccal and blood cells
were examined [19], and in up to 88% of individuals when PHPs
across several tissue types from the same individual were
combined [23]. The variable rates observed in different studies
are primarily accounted for by differences in the (1) tissue types,
and (2) populations examined. The incidence of PHP in tissues
with high metabolic activity (e.g. 79% in muscle [23]) has been
generally higher than in blood or blood-derived specimens (4–8%
[23,67]), though a recent study also found high rates of PHP in 18%
of the investigated individuals, albeit with more sensitive
detection criteria [23]. In general, the CR nucleotide positions
at which PHP has been most frequently observed are consistent
with the positions with the highest substitution rates [19].
There are a few notable exceptions, however. In particular,
PHP at position 16,093 has often been observed at rates more
than double any other CR position, despite a substitution rate
that is considerably lower than other variable sites in the CR
[7,23,71–73].
Though the incidence of LHP in the CR also varies by population
and sample type, the picture derived from examinations of
homopolymer regions of the CR across numerous studies is
consistent: LHP is observed always or nearly always when tracts of
nine or more identical nucleotides are present, sometimes with
tracts of eight identical nucleotides, and very rarely with tracts of
seven or fewer identical nucleotides (e.g. [74]). In the AC repeat
region ending at position 524, LHP has been detected when the
majority molecule had as few as ﬁve repeats, but more commonly
when six or more repeats are present (www.empop.org [75]).
Despite the fact that some 20,000 complete human mtGenomes
are now publicly available, it is only within the past few years – and
concurrent with the expanding use of MPS technologies for
mtGenome sequencing – that detailed reports on heteroplasmy in
the mtDNA coding region have begun to emerge. The few Sanger
and MPS-based population datasets that have assumed or applied
heteroplasmy detection thresholds ranging from approximately
10% to 20% have produced remarkably similar pictures of PHP
across the full mtGenome (Fig. 1 and Table S1). At this level of
detection, roughly 25% of individuals have at least one PHP, and no
more than a handful of PHPs are observed in any one individual
[38,52,67,68]. In addition, and similar to the CR, variation in PHP
rates by population was also observed [68]. When the PHP data
from these studies were considered in combination, they
suggested that coding region PHP hotspots may be rare or
nonexistent, and that patterns of PHP and substitution in the
Fig. 1. Heteroplasmy rates and features reported in Sanger and MPS-based datasets. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
Rates and features of the mtGenome heteroplasmy reported in two Sanger-based [67,68] and eight MPS-based [24,38,39,42–44,46,52] datasets. The Ye et al. data are based on
an analysis of the original dataset [43] with the 63 samples noted by the authors as likely mixtures removed [79]. The data plotted from Ref. [24] are averages of the four
reported quartiles. The data from Ref. [46] are based on the 139 blood specimens. All of the data represented in this ﬁgure and further details for each study are presented in
Table S1.
The bar graphs in the ﬁgure represent the percentage of individuals (or lineages, in the case of Ref. [24]) in each study that exhibited heteroplasmy at the applied detection
levels (left y-axis). In the three studies in which an MAF was associated with each reported heteroplasmy [24,43,46], the proportion of the heteroplasmy detected at different
MAFs is noted (in stacked bars). The percentage of individuals with PHP at the 10–20% detection level (blue bars) is consistently around 25% in six studies (see the blue-dashed
box), but is much higher at this same detection level in two other MPS-based reports [39,43]. The black diamonds, plotted on the secondary (right) y-axis, represent the
maximum number of PHPs reported for any single individual each dataset. Despite a very wide range of applied or estimated heteroplasmy detection thresholds (0.1–20%),
seven of the ten studies (see the black-dashed box) had a low maximum number of observed PHP (fewer than 10). By contrast, three datasets [39,42,43] had much higher
values – including greater than 80 PHP reported for a single individual in Ref. [42]. Finally, the green squares (plotted on the left y-axis) represent the percentage of coding
region PHPs that were unique in each study (observed in only a single individual). While this value clearly may be impacted by both the number of individuals examined and
the detection threshold applied, the percentage of unique coding region PHP was less than 90% in only two studies [42,43]. It is worth noting that both of those examinations
of heteroplasmy used the 1000 Genomes Project [48] mtGenome data, which has been previously shown to include at least some cross-sample contamination [78]. The
percentage of coding region PHP that were unique for each of the remaining studies falls within a relatively narrow range (green-dashed box).
134 R.S. Just et al. / Forensic Science International: Genetics 18 (2015) 131–139coding region may not be correlated [68] as is generally the case in
the CR [19].
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.05.003.
A number of MPS-based studies of heteroplasmy across the full
mtGenome, most of them based on a substantially lower
heteroplasmy detection threshold, have reported higher rates
and/or different patterns of PHP than those observed in the
above-referenced datasets. The ﬁrst high-proﬁle report on
heteroplasmy in MPS-based mtGenome data was published in
Nature in 2010 [37]. The authors described universal presence of
heteroplasmy in normal colon tissue from ten individuals when
using a <2% detection threshold, with an average of four PHP per
individual. In a critique of that study, Bandelt and Salas [76] found
an average of ﬁve errors in the homoplasmic variants reported for
those specimens – indicating some general issues with the He et al.
data. Those authors also found inconsistencies in the rate and
pattern of the He et al. CR heteroplasmies in comparison to the
comprehensive Sanger-based study by Irwin et al. [19]. Other
authors have suggested the He et al. data may not be fully reliable
due to Illumina chemistry-based sequencing errors mistaken as
heteroplasmy, or the use of lymphoid cell lines [45,46].
A more recent paper [39] reported a very high number of PHP in
some of the 40 control DNA samples examined, along with an
incidence of 65% PHP in the samples overall. These observations
were based on the application of a 10% minor variant (or “minor
allele frequency”, MAF) threshold for detection – the same
threshold used in four other studies to establish the presence of
heteroplasmy in only 25% of individuals tested. However, when the
positions at which PHP was observed are examined further, it is
clear that some of the mixed bases are the result of mixture
between distinct mtDNA haplotypes rather than authenticheteroplasmy. For example, of the ten PHP reported for sample
NA121245, eight are diagnostic for haplogroup K1b1a1 (according
to Build 16 of PhyloTree [77]).
Similar problems were detected in a recent high-proﬁle report
on heteroplasmy [43], which examined mtDNA data from the
1000 Genomes Project (http://www.1000genomes.org). As we
[68,78] and other authors [44] have described, the presence of
distinct mtDNA haplogroup motifs among the heteroplasmies
listed for a number of the samples indicates that at least some of
the reported PHP is contamination rather than intraindividual
variation. In a reexamination of their original data, Ye et al.
identiﬁed 63 samples in which mixtures may be present and
removed these from their dataset [79]. While these may represent
“only” 5.8% of the original sample set of 1085, the discarded
samples account for more than 22% of the heteroplasmy initially
reported by Ye et al. Further, they comprise all of the samples for
which the authors originally described more than 15 PHP per
individual. The revised Ye et al. dataset still appears to be unusual
in a few respects, especially in light of other reports on mtDNA
heteroplasmy that employed various detection thresholds (see
Fig. 1 and Table S1). For example, the data still reﬂect an unusually
high percentage of individuals with heteroplasmy (even when a
10% PHP ﬁlter is applied to the data), a low percentage of coding
region PHPs that are unique, a high frequency of uncommon coding
region variants (for example, 29 instances of PHP at position 3579)
which suggests that sequencing error has likely been mistaken as
heteroplasmy, and the persistence of distinct haplogroup motifs
among the PHP in at least a few of the non-excluded samples.
A separate study of mtDNA heteroplasmy published in 2014
also utilized data from the 1000 Genomes Project [42]. After
ﬁltering for NUMT-like sequences and PCR duplicates, the authors
reported average mtGenome sequence coverage ranging from
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approximately 1% MAF detection threshold for at least some
mtGenome positions. The study reported an average of 7.75
heteroplasmies (PHP and LHP inclusive) per sample across more
than 1200 individuals, with a maximum number of PHP
described for a single individual greater than 80. Examination of
the position-speciﬁc incidence of PHP in the CR and the codR
reported in this study (obtained from Additional File 9 in [42],
and displayed in part in Table S2) reveals some highly unusual
patterns. For instance, 21 positions, including multiple coding
region positions, have a higher frequency of PHP than position
16,093 – which past studies have repeatedly demonstrated has the
highest rate of PHP in the CR [10,18,19,68,71,80]. As an extreme
example, the number of PHP reported for position 513 was more
than 8-fold greater than the incidence of PHP at 16,093; yet in an
earlier, Sanger-based study of heteroplasmy in more than 5000 CR
haplotypes, not a single instance of PHP at position 513 was
detected [19]. Similarly, the Irwin et al. examination found zero
instances of PHP at position 247, but Diroma et al. report PHP at
247 at twice the rate of 16,093. Further, among the 26 positions
with the highest incidence of PHP in the Diroma et al. dataset,
18 exactly match the sequence motif for macrohaplogroup N;
and several other complete haplogroup motifs can be seen
among the PHP with lower reported frequencies. These obser-
vations clearly point to widespread problems in the dataset,
which in the above examples are mostly likely the result of both
mixtures/contamination and sequence alignment issues.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.05.003.
In sharp contrast to these problematic reports, a recent study
that developed extremely high depth Illumina sequence coverage
(20,000) and a custom data analysis pipeline to examine the
transmission of heteroplasmy in mother–child pairs found a
substantially smaller maximum number of heteroplasmies per
individual [24]. With some PHP detected at MAFs as low as
0.1% – 10-fold lower than the MAF threshold applied in the Ye et al.
[43] and Diroma et al. [42] examinations – an average of 78% of
individuals possessed heteroplasmy in the Rebolledo-Jaramillo
et al. study, and the maximum number of PHP observed in any
single sample was seven [24]. When we applied a 1% MAF cut-off to
the data, an average of 63% of individuals had at least one PHP, and
the maximum number of heteroplasmies per sample was ﬁve
(Fig. 1 and Table S1). When a 10% MAF threshold was applied, an
average of 24% of individuals possessed a PHP, and the maximum
number of PHP per sample was two – a result that is strikingly
consistent with previous Sanger sequencing studies in which
heteroplasmy detection thresholds were roughly 10% or greater.
Similarly, the recent report on mtGenome heteroplasmy from
Skonieczna et al. found a maximum of just two PHP within a single
individual. Overall, the authors found heteroplasmy in 32% of
50 individuals, despite including a number of heteroplasmies
observed at a variant frequency of just 2% [44].
Though the heteroplasmy data from these two recent studies
are based on a smaller sample size (39 mtDNA lineages and
50 individuals, respectively) than other MPS-based examinations,
it is notable that the only positions at which PHP was observed as
shared (detected in more than one lineage) in either study were in
the CR, and that the 74 total coding region positions at which PHP
was detected across the two studies do not overlap with any of the
heteroplasmic positions captured from more than 1100 complete
mtGenomes in earlier reliable reports (Li et al. [38], Ramos et al.
[67], King et al. [52], and Just et al. [68] datasets; see Table S3). That
is, when the coding region PHP data from these six studies are
combined, 261 of 279 coding region PHP (93.5%) are unique across
the approximately 1200 total mtGenomes, and no single coding
region PHP is observed in more than two individuals. The data fromthese two studies are thus consistent with earlier reports in these
key respects, and they further support the notion that coding
region PHP hotspots (as exist in the CR) may be rare or nonexistent.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.05.003.
Yet another very recent and in-depth examination of mtDNA
heteroplasmy, based on high coverage depth MPS data and a low
PHP detection threshold, also appears to be consistent with these
ﬁndings. Earlier this year, Li et al. [46] published an analysis of
complete mtGenomes from 12 tissue types from 152 total
individuals. Across all tissue types and individuals, PHPs present
at a MAF of 0.5% or greater were observed at 179 different coding
region positions. When the heteroplasmy data for a single tissue
type (blood) was assessed (with individual 272 removed due to
probable mixture given multiple positions speciﬁc to mtDNA
haplogroup H3g1b [77]), PHPs present at a MAF of 0.5% or greater
were found in 80.6% of individuals, 90% of the coding region PHP
were unique to a single individual, and the maximum number of
PHP found in a single individual was eight. With the application of
a 10% detection threshold, 22.3% of individuals possessed at least
one PHP, and no individual had more than two PHP. As Fig. 1 and
Table S1 demonstrate, all of these values are highly similar to other
seemingly reliable reports on mtDNA heteroplasmy.
The examination of heteroplasmy in new MPS-based reports in
comparison to consensus observations from previous reliable
reports that are detailed above highlight an important and useful
strategy for assessing mtGenome data developed using new
technologies. MtDNA data that have been carefully generated,
comprehensively examined with respect to well-known sources of
error, and shown to be of high quality can and should be used to
develop expectations regarding the prevalence and pattern of
mtGenome variation. Such datasets can be used as benchmarks
against which new datasets can be evaluated. This is especially
important when considering very low-level heteroplasmy detec-
tion in MPS-based datasets, since comparative data from
methodologies that have been fully validated for forensic use
(i.e. Sanger sequencing) will be unavailable. When new MPS-based
mtDNA data do not exhibit any obvious signs of errors (for instance,
haplogroup-speciﬁc motifs or high rates of heteroplasmy at
unusual positions) and are consistent with the expected patterns
of variation at a common level of resolution (e.g. 10%), there can be
greater conﬁdence that the sequence variants detected at lower
levels are authentic. Conversely, when the data appear to differ
substantially from the expected patterns, more thorough investi-
gation of the potential cause(s) for the discrepancies would be
prudent.
The coding region PHPs reported in the recent Li et al. study
include one such feature that is anomalous in comparison to prior
reports. Among the 192 total coding region PHP the authors
detected at MAFs  0.5% across all 12 tissue types (again excluding
individual 272), PHP at position 12,684 was found in four
individuals, and PHP at position 12,705 was identiﬁed in six
individuals (see Dataset S1 in [46]). For these two positions the
heteroplasmy was always evident in the blood specimens at
relatively low MAFs (2.1–4.2%) with the rCRS variant as the
majority type, and in all but one individual was found in at least
one additional tissue type at very low MAF (0.5–1.0%). No PHP at
these two positions was detected in the earlier datasets captured in
Table S3, including the Rebolledo-Jaramillo et al. data that were
developed from blood specimens analyzed using a 0.1% MAF [24],
and both positions have low relative substitution rates according to
[73]. Yet PHP at these two positions co-occurred in three
individuals in the Li et al. study, in a single tissue type (blood)
at a rate greater than would be expected by chance [46]. When we
performed a blastn search of GenBank using a text string that
included the minor sequence variant at both positions
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human results represented a NUMT on Chromosome 13. But
several of the other 100% matches were to mtGenomes published
in peer-reviewed studies, and both 12,684 and 12,705 are third
codon positions (in the ND5 gene). Thus, though the multiple PHPs
at these two positions appear to be quite unusual and are worth
noting as such, it is difﬁcult to conclusively determine whether
they represent authentic intraindividual mtDNA variation or not.
When the coding region PHP from the recent Li et al.
examination are combined with data from earlier reports, a
greater number of PHP are observed in more than one individual,
as would be expected as the total number of mtGenomes examined
using low MAF thresholds and the number of PHP detected
increase (compare Tables S4 to S3). Yet still only 26 of the
437 distinct heteroplasmic positions found among the 1343 total
individuals/lineages (derived from 3073 complete mtGenome
sequences) were observed more than once (Table S4). When the
PHP at positions 12,684 and 12,705 from Li et al. are ignored, 89.2%
of the PHP were unique to a single individual, PHP at 22 positions
was observed in two individuals, and just two PHP were observed
in three individuals. A linear regression analysis of the combined
data indicates that little of the total variance in the incidence of
coding region PHP is explained by the relative substitution rates of
coding region positions (r2 = 0.0449; Fig. S2), and the 22 PHPs
detected in two distinct individuals were found at positions that
range from highly variant to invariant among the 2000+
mtGenomes examined by Soares et al. [73]. However, the two
coding region positions at which PHP was observed in three
individuals (positions 709 and 12,007) both have high relative
substitution rates, and the proportion of PHP observed at positions
variant (versus invariant) in the Soares et al. analysis is greater than
would be expected by chance (two-tailed p < 0.0001). This
constellation of ﬁndings is both sensical and consistent with
recent analyses of heteroplasmy that seem to demonstrate a
degree of functional constraint imposed on random mutation in
the coding region that is short of the more extensive selection
detected when complete substitutions are examined [24,46,67,68].
Additional reliable PHP data (and, ideally, a reﬁned estimation of
position-speciﬁc rates) will be needed to clarify the relationship
between the likelihood of observation of heteroplasmy in relation
to mutation and substitution rates in the coding region, and to
determine whether any true heteroplasmic hotspots exist in the
coding region.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.05.003.
LHP has been largely ignored in MPS-based mtDNA examina-
tions to date, with the exception of two studies that developed
extremely high sequence coverage depths [24,81], and one other
study that reported numerous erroneous LHPs [42]. And although
LHP is not routinely used in forensic match comparisons of
Sanger-based CR haplotypes [14,15], accurate sequence alignment
in LHP regions will likely still be desirable as the ﬁeld transitions to
MPS for routine mtDNA data generation. Particular regions in
which LHP is encountered contain phylogenetically relevant
information (for example, variation at 16,189, and with the 9 base
pair coding region repeat), and thus accurate and consistent
reﬂection of the template in these regions will be important. In
addition, improper alignment of sequence reads when LHP is
present can lead to erroneous haplotypes due to miscalled
indels, complete substitutions, and heteroplasmy. This issue has
previously resulted in phantom mutations in Sanger-based mtDNA
data [82], and appears to be the cause of some specious
heteroplasmies (both point and length) described in one of the
few MPS-based studies that has attempted to report LHP [42].
Regardless of the MPS chemistry or platform employed,
sequence data in homopolymer regions are likely to continue tobe challenging to assemble and align when LHP is present. If
sequence reads are mapped with respect to a reference sequence
(such as the rCRS [83]), the particular reads that are mapped or
discarded will depend upon the underlying algorithm of the
chosen assembler/software program as well as the stringency of
the base mismatch and length similarity parameters applied
(assuming these latter two features can be adjusted with the
selected assembler). And clearly, the number and complexity of the
variant molecules in cases of LHP may impact the difﬁculty of
alignment and the accuracy with which the authentic template
sequences are detected due to reference bias [84–86]. That is, in
cases of simple insertions of one or more nucleotides, assembly of
the reads against the rCRS may be fairly uncomplicated as the
template sequences will not differ greatly from the reference
sequence; but in situations in which the mixture of mtDNA
molecules are more dissimilar to the reference sequence, those
reads which align will be biased toward those most similar to the
reference. Additionally, a higher rate of non-random sequencing
error in GC-rich regions may result in sequences with low quality
scores that will be ﬁltered out during secondary data processing
[55]. This could further complicate data interpretation in C-tracts
in particular.
In considering how assembly in mtGenome regions prone to
LHP (as well as simple indels) may be addressed, one common-
sense step would be to use only those sequence reads which span
the entire homopolymeric or repeat region (i.e. reads which
include portions of the 30 and 50 ﬂanking sequence) to determine
the template sequence(s) for the region – as sequence reads which
end within the tract will not provide useful information, and
indeed may confound interpretation [45]. In addition, an approach
that utilizes multiple reference sequences representing known
variation in the region could potentially be useful in some
instances, both to capture all sequence reads for the region and
to avoid reference bias. For example, indels of the repeated 9 bp
motif at positions 8272–8289 are structurally similar to nuclear
short tandem repeats (STRs). In this case, both (1) LHP of the 9 bp
repeat itself, and (2) LHP within the 9 bp repeat region (as was
observed in mtGenomes reported in [68]) may prove challenging
to align to the rCRS and accordingly suffer from reference bias.
One strategy that has been used to develop accurate allele calls for
MPS-based STR data was the development of reference sequences
for known alleles for each STR marker, and subsequent mapping
of the MPS data against the set of references for each marker
using stringent sequence similarity requirements (to ensure
assembly to the correct reference sequence among multiple
similar references) [87]. With this approach it seems that length
variants in the 9 bp repeat region could be fully captured,
accurately detected, and in cases of LHP, approximately quantiﬁed.
Testing would clearly be required to assess how well this
multiple reference alignment method or a similar strategy could
work for mtDNA (rather than STR) data, and for which types
of length variants it may have utility (e.g. repeats versus
homopolymeric tracts, simple indel LHP versus LHP combined
with substitutions). Alternative approaches that speciﬁcally
consider the size of the fragments spanning LHP and indel-prone
regions may also be considered. These methods also use de novo
alignment and have been shown to work for MPS-based STR
analysis [88]. While this strict amplicon-size/read-length
approach currently employed for STRs may not be ideal for
mtDNA purposes, some variation could potentially be used for
repeat and indel regions of the mtGenome. Additionally, if the
speciﬁc sequence reads which span particular LHP or indel-prone
regions can be identiﬁed and sequestered from the remainder of
the data, a de novo assembly of only those reads would be
plausible. It also seems feasible that where limitations in sequence
alignment algorithms prevent reliable placement of indels
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but consistent results are obtained using the selected data analysis
pipeline, the variant calls for the relevant regions could be
transformed bioinformatically prior to reporting.
Regardless of the particular method(s) applied, it seems evident
that known LHP regions should be afforded some degree of
specialized handling, distinct from the routine processes applied
to either sequence alignment or variant calling in the remainder
of the genome. To accomplish this, it will be essential to develop
a catalog of the mtGenome regions in which LHP has been
observed, and to have a background understanding of the
conditions that frequently result in LHP (i.e. homopolymeric tracts
of eight or more identical nucleotides). With this knowledge, we
can begin to develop and apply methods to screen for, identify
and accurately report LHP in mtGenome haplotypes derived from
MPS data.
4. Summary and outlook
The application of highly sensitive MPS techniques to the
analysis of mtDNA has the potential to improve the recovery of
genetic information from difﬁcult forensic specimens, and increase
the discrimination potential of mtDNA via the capture and
comparison of full mtGenomes. Several studies to date have
harnessed the generally increased sensitivity of MPS technologies
to examine purported low frequency mtDNA variants observed in
heteroplasmic state, but in a number of these reports authentic
mtDNA heteroplasmy has not been fully distinguished from other
sources of mixed data. Given the differences in the sensitivity of
Sanger sequencing and MPS to heteroplasmy detection and thus
the greater opportunity to detect low-level, non-target DNA
that may give rise to the appearance of heteroplasmy, together
with the requisite differences in data handling due to data
volume, the reliable identiﬁcation of heteroplasmy in MPS data
will need to depend heavily on the development and application
of bioinformatic processes. The development of such tools
should be based on, among other things: (1) the mtDNA phylogeny,
(2) known patterns of mtDNA heteroplasmy and mutation
derived from well-vetted datasets, (3) known NUMT sequences,
(4) MPS chemistry artifacts and (5) data alignment artifacts.
Robust and reliable automated processes should greatly simplify
the discernment of authentic intraindividual variation from
other sources of mixed MPS-developed mtDNA data.
Despite substantial differences between Sanger and MPS
typing methods, the approach to authenticating heteroplasmy is
fundamentally the same in both cases. It involves recognition of
the potential causes of mtDNA mixtures aside from heteroplasmy,
an understanding of their potential for impact on the data, and
systematic methods for developing and applying criteria that
address these causes. With a careful and methodical approach,
there would seem to be no question that MPS can dramatically
improve our understanding of mtDNA heteroplasmy and mutation,
leading to further reﬁnement of its treatment and utility in forensic
mtDNA casework.
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